Meet the EnzyTag team


Leendert van den Bos


Leendert van den Bos obtained his MSc- and PhD-degree in bio-organic chemistry from Leiden University. He joined Organon BioSciences as a Scientist in 2007 and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development. Leendert also holds an Executive MBA from Nyenrode University.

Rodney Lax

Business Development Consultant

Dr. Rodney Lax was trained as a biochemist in the UK and worked many years in academia amongst others as Associate Professor of Physiological Chemistry at the University of Essen in 1985. From 1986 onwards, he focused his attention on peptide therapeutics, working at a number of small biotech and manufacturing organizations including PolyPeptide Group and EnzyPep. Dr. Lax has been Director on the Board of the Peptide Therapeutics Foundation and is a member of Boulder Peptide Society Scientific Advisory Board.

Robert Naasz

Business Development Consultant

Dr. Robert Naasz obtained his PhD in Organic Chemistry at the University of Groningen with Nobel prize winner Prof. B.L. Feringa. He joined Diosynth (Oss, The Netherlands) as a Scientist in 2002 and worked subsequently for Organon Biosciences, Schering-Plough, Merck Sharp & Dohme mostly in the field of Process Research & Development. From 2010 onwards Robert was responsible for strategic sourcing and purchasing for the Aspen Pharmacare API production site in Oss, running various high impact sourcing projects with companies in Asia. In 2019 he joined EnzyTag as Business Development Manager responsible for the Asia region.

Please feel free to contact us

EnzyTag is open to further discussions on technology licensing for commercial purposes.

We use cookies to ensure that our website runs as smoothly as possible and to analyze web traffic. If you continue to use the website, you agree with our Privacy Policy. I agree